179 related articles for article (PubMed ID: 36290835)
1. Treatments for Non-Small-Cell Lung Cancer: The Multiple Options for Precision Medicine.
Pons-Tostivint E; Bennouna J
Curr Oncol; 2022 Sep; 29(10):7106-7108. PubMed ID: 36290835
[TBL] [Abstract][Full Text] [Related]
2. Advancements in NSCLC: From Pathophysiological Insights to Targeted Treatments.
Xu J; Tian L; Qi W; Lv Q; Wang T
Am J Clin Oncol; 2024 Jun; 47(6):291-303. PubMed ID: 38375734
[TBL] [Abstract][Full Text] [Related]
3. Toward personalized treatment approaches for non-small-cell lung cancer.
Wang M; Herbst RS; Boshoff C
Nat Med; 2021 Aug; 27(8):1345-1356. PubMed ID: 34385702
[TBL] [Abstract][Full Text] [Related]
4. Precision medicine in non-small cell lung cancer: Current applications and future directions.
Yang SR; Schultheis AM; Yu H; Mandelker D; Ladanyi M; Büttner R
Semin Cancer Biol; 2022 Sep; 84():184-198. PubMed ID: 32730814
[TBL] [Abstract][Full Text] [Related]
5. Personalizing therapy in advanced non-small cell lung cancer.
Villaruz LC; Burns TF; Ramfidis VS; Socinski MA
Semin Respir Crit Care Med; 2013 Dec; 34(6):822-36. PubMed ID: 24258572
[TBL] [Abstract][Full Text] [Related]
6. [Personalized therapy of lung cancer - current standard and future challenges].
Riedel R; Wolf J
Dtsch Med Wochenschr; 2017 Nov; 142(22):1660-1668. PubMed ID: 29078211
[TBL] [Abstract][Full Text] [Related]
7. Emerging therapeutic agents for advanced non-small cell lung cancer.
Chen R; Manochakian R; James L; Azzouqa AG; Shi H; Zhang Y; Zhao Y; Zhou K; Lou Y
J Hematol Oncol; 2020 May; 13(1):58. PubMed ID: 32448366
[TBL] [Abstract][Full Text] [Related]
8. The lung and winding road: twists and turns on the way to personalized NSCLC therapy.
Milella M
Curr Pharm Des; 2014; 20(24):3861-2. PubMed ID: 24191957
[No Abstract] [Full Text] [Related]
9. Personalized medicine in lung cancer: what we need to know.
Mok TS
Nat Rev Clin Oncol; 2011 Aug; 8(11):661-8. PubMed ID: 21862980
[TBL] [Abstract][Full Text] [Related]
10. [The molecular markers related to personalized therapy of non-small cell lung cancer].
Guo N; Yu C; Yu C
Zhongguo Fei Ai Za Zhi; 2011 Mar; 14(3):292-6. PubMed ID: 21426677
[No Abstract] [Full Text] [Related]
11. Management of non-small cell lung cancer in the era of personalized medicine.
Rocco G; Morabito A; Leone A; Muto P; Fiore F; Budillon A
Int J Biochem Cell Biol; 2016 Sep; 78():173-179. PubMed ID: 27425397
[TBL] [Abstract][Full Text] [Related]
12. Precision Medicine in Non-Small Cell Lung Cancer: Current Standards in Pathology and Biomarker Interpretation.
Brown NA; Aisner DL; Oxnard GR
Am Soc Clin Oncol Educ Book; 2018 May; 38():708-715. PubMed ID: 30231309
[TBL] [Abstract][Full Text] [Related]
13. Understanding Lung Cancer Treatment Advances.
Oncology (Williston Park); 2019 Dec; 33(12):. PubMed ID: 31914203
[No Abstract] [Full Text] [Related]
14. The Evolving Role of Biomarkers in Personalized Lung Cancer Therapy.
Sharma J; Shum E; Chau V; Paucar D; Cheng H; Halmos B
Respiration; 2017; 93(1):1-14. PubMed ID: 27894113
[No Abstract] [Full Text] [Related]
15. What are the options for non-small-cell lung cancer patients post second-line therapy?
Cortinovis DL; Canova S; Bidoli P
Future Oncol; 2015; 11(17):2379-82. PubMed ID: 26270000
[No Abstract] [Full Text] [Related]
16. Targeted therapy of oncogenic-driven advanced non-small cell lung cancer: recent advances and new perspectives.
Genova C; Rossi G; Tagliamento M; Rijavec E; Biello F; Cerbone L; Zullo L; Grossi F
Expert Rev Respir Med; 2020 Apr; 14(4):367-383. PubMed ID: 31917616
[No Abstract] [Full Text] [Related]
17. [Targeted therapies in non-small cell lung cancer in 2014].
Leduc C; Besse B
Rev Mal Respir; 2015 Feb; 32(2):182-92. PubMed ID: 25704901
[TBL] [Abstract][Full Text] [Related]
18. Identification of driver mutations in lung cancer: first step in personalized cancer.
Planchard D
Target Oncol; 2013 Mar; 8(1):3-14. PubMed ID: 23371030
[TBL] [Abstract][Full Text] [Related]
19. A Radiologist's Guide to the Changing Treatment Paradigm of Advanced Non-Small Cell Lung Cancer: The ASCO 2018 Molecular Testing Guidelines and Targeted Therapies.
Chen L; Smith DA; Somarouthu B; Gupta A; Gilani KA; Ramaiya NH
AJR Am J Roentgenol; 2019 Nov; 213(5):1047-1058. PubMed ID: 31361530
[No Abstract] [Full Text] [Related]
20. [Lung cancer. Molecular pathology and personalized therapy].
Schultheis A; Wolf J; Büttner R
Internist (Berl); 2013 Feb; 54(2):179-80, 182-7. PubMed ID: 23371257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
